ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Tobacco Council Grants Total 3,348

July 15, 1988

P01 Reviewers Asked To Look Closely At Number Of Projects

October 2, 1992

Anidulafungin Safe And Well-Tolerated In Pediatric Patients With Neutropenia

November 26, 2004

AACI Adopts Plan To Step Up Cancer Issues Involvement

January 25, 1980

Masons Give $65 Million to Univ. of Minnesota Cancer Center.

April 25, 2008

Program Announcement Completes NCI switch To Control Research

April 16, 1982